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ABSTRACT: Lipids are a major source of energy for most tissues, and
lipid uptake and storage is therefore crucial for energy homeostasis. So
far, quantification of lipid uptake in vivo has primarily relied on
radioactive isotope labeling, exposing human subjects or experimental
animals to ionizing radiation. Here, we describe the quantification of in
vivo uptake of chylomicrons, the primary carriers of dietary lipids, in
metabolically active tissues using magnetic particle imaging (MPI) and
magnetic particle spectroscopy (MPS). We show that loading artificial
chylomicrons (ACM) with iron oxide nanoparticles (IONPs) enables rapid and highly sensitive post hoc detection of lipid
uptake in situ using MPS. Importantly, by utilizing highly magnetic Zn-doped iron oxide nanoparticles (ZnMNPs), we
generated ACM with MPI tracer properties superseding the current gold-standard, Resovist, enabling quantification of lipid
uptake from whole-animal scans. We focused on brown adipose tissue (BAT), which dissipates heat and can consume a large
part of nutrient lipids, as a model for tightly regulated and inducible lipid uptake. High BAT activity in humans correlates with
leanness and improved cardiometabolic health. However, the lack of nonradioactive imaging techniques is an important
hurdle for the development of BAT-centered therapies for metabolic diseases such as obesity and type 2 diabetes. Comparison
of MPI measurements with iron quantification by inductively coupled plasma mass spectrometry revealed that MPI rivals the
performance of this highly sensitive technique. Our results represent radioactivity-free quantification of lipid uptake in
metabolically active tissues such as BAT.
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Adipose tissues are the major sites of lipid storage. Thereare two major types of adipose tissue, white adiposetissue (WAT) and brown adipose tissue (BAT).1 BAT
is an organ that is capable of converting chemical energy into
heat by mitochondrial uncoupling.2,3 Since the discovery of
metabolically active BAT in adult humans in 2007/9,4−8 it has
been the subject of intense research due to the possibility of
exploiting its thermogenic properties for combating obesity,
diabetes, dyslipidemia, and cardiovascular disease.9−11 During
the process of thermogenesis in BAT, there is a dramatic
increase in the demand for energy substrates, and ca. 50−75%
of the food-derived lipids and glucose, respectively, are taken
up by activated BAT.12−16 Consequently, quantification of
lipid uptake in BAT is a highly valuable tool both to measure
BAT activity and to develop ways to measure lipid transport
and storage. Additionally, safe and noninvasive measurements
of BAT activity in humans would be an important prerequisite
for the development of antiobesity drugs.
Lipoprotein particles are composed of triglycerides,
phospholipids, and cholesterol and are associated with
apolipoproteins (ApoA, ApoB, ApoC, and ApoE), which
confer functionality and tissue targeting capabilities.17,18
Classification of lipoprotein particles is based on particle size
and density: high-density lipoprotein particles (HDL), low-
density lipoprotein particles (LDL), intermediate-density
lipoprotein particles (IDL), and very low density lipoprotein
particles (VLDL) range from 5 to 100 nm in diameter,
respectively, and take part in lipid transport between the liver
and peripheral tissues. Ultra-low-density lipoprotein particles
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(ULDL), also known as triglyceride-rich lipoprotein particles
(TRL) or chylomicrons, are between 100 and 1000 nm in
diameter and represent the primary means of transport for
dietary lipids between the gut and peripheral tissues.18,19
Artificial lipoprotein particles have found a variety of uses in
research, including analysis of nutrient uptake and lipid
metabolism, diagnostics, and immunotherapy.13,20,21 Uptake
of chylomicrons in tissues is canonically mediated by
lipoprotein lipase at the endothelium, followed by import of
the free fatty acids into the tissue.17,22,23 Alternatively,
lipoprotein particles can undergo whole-particle internalization
and transcytosis through the endothelium.13 Activated BAT
efficiently takes up lipoprotein particles, and the majority of
intravenously administered lipoprotein particles are cleared
from the serum within minutes.13
Currently, the only imaging technique commonly used for
detecting nutrient uptake in humans is positron emission
tomography−computed tomography (PET-CT), which in-
volves administering a cumulative dose of ionizing radiation of
around 30 mSv for a single round of image acquisition.24 As
this poses a significant health risk for involved subjects,
techniques for radiation-free BAT activity measurements are
urgently needed. Additionally, the tracers used for metabolic
PET-CT imaging, typically [18F]FDG for glucose or
[18F]FTHA for lipids, both have drawbacks that limits their
use for assessing BAT activity. First, obese subjects are
typically diabetic and exhibit impaired cold-induced glucose
uptake (and thereby [18F]FDG), but not fatty acids.25 Second,
it is currently not possible to measure BAT volume directly
using [18F]FTHA due to insufficient radioactivity contrast
between BAT and WAT. To circumvent these issues, attempts
have been made to measure BAT activity with magnetic
resonance imaging (MRI). Using dynamic T2*-imaging, signal
fluctuations that correlate with whole-body cooling can be
detected, but so far this technique has been hampered by low
specificity and contrast.26 MRI has also been used in
experimental animal models to detect iron oxide-loaded
chylomicrons for semiquantitative measurements.27 Other
methods for assessing BAT activity have been investigated,
such as hyperpolarized 13C-MRI imaging to detect metabolite
turnover and contrast ultrasound to detect changes in blood
flow (although this is limited to superficial tissues).28,29
Here, we describe quantification of in vivo lipid uptake using
magnetic particle imaging (MPI) and magnetic particle
spectroscopy (MPS). The MPI/MPS signal is derived from
the nonlinear magnetization curve of superparamagnetic
particles,30 a phenomenon that does not occur in biological
tissues. MPI is an emerging imaging technique that enables not
only three-dimensional imaging but also quantification of
magnetic nanoparticles (MNPs) in vivo.31,32 MPI imaging
offers several advantages over current clinically used imaging
techniques, such as zero signal tissue attenuation, radiation-free
tracers, and high spatial and temporal resolution.32 Unlike
MRI, the tracers in MPI are the only source for signal, leading
to extremely high contrast. Furthermore, MRI-based measure-
ments of MNPs require a reference scan prior to particle
administration, and the sensitivity of MRI-based MNP
detection has been reported to be more than 20 times lower
compared to MPI.33 To date, MPI has primarily been used for
cell tracking. vascular imaging, and MPI-guided hyperthermia
therapy.34−38 We show that by using tailored Zn-doped MNPs
(ZnMNPs), MNP-loaded chylomicrons enable high-resolu-
tion, nonradioactive imaging and quantification of metabolic
activity in vivo using MPI. As a model for induced, tissue-
specific lipid uptake, we use BAT activation by acute cold
exposure and show that MPI detection of internalized MNPs
provides an accurate and safe way of detecting alterations in
lipid uptake noninvasively. Additionally, we show that the
uptake can be quantified ex vivo with high sensitivity in any
type of tissue with minimal background noise using MPS
(zero-dimensional MPI) using relatively inexpensive and
commercially available reagents and equipment.
Figure 1. Characterization of IONP-ACM. (a) Size distribution of IONP-ACM as measured by dynamic light scattering (DLS). (b)
Representative cryo-TEM image of IONP-loaded ACM. Dashed line outlines the circumference of the ACM. (c) Quasi-static magnetization
curves of three batches of IONP-ACM, with Resovist and the IONPs used for loading as reference. (d) Dynamic magnetization
measurements of three batches of IONP-ACM, with Resovist and the IONPs used for loading as reference; n represents the harmonic
number. IONP-ACM data are presented as means ± SEM.
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RESULTS AND DISCUSSION
Artificial chylomicrons (ACM) were synthesized by mixing
phosphatidylcholine (PC), triglycerides (TG), and cholesterol.
To optimize particle size, the TG content was varied, resulting
in an optimal size distribution between 100 and 1000 nm at a
TG to PC mass ratio of 16:1 (Figure 1a), with a mean
hydrodynamic diameter of 387.2 ± 13 nm (Supplementary
Figure 1a). For initial experiments using MPS, we loaded ACM
with oleic acid-stabilized iron oxide magnetic nanoparticles
(IONPs) with a diameter of 20 nm. Incorporation of IONPs in
the triglyceride core only slightly decreased the mean
hydrodynamic diameter (338.6 ± 9 nm), with no discernible
effect on polydispersity index or Z-potential (Supplementary
Figure 1b,c). The potential size distribution bias of IONP-
loaded ACM was investigated by pulling down highly magnetic
IONP-ACM with a permanent magnet and measuring the
hydrodynamic size of pulled down ACM and the ones in the
nonmagnetic supernatant. We found that highly magnetic
IONP-ACM had a slightly higher mean hydrodynamic
diameter, but that both fractions showed size distributions
characteristic of chylomicrons (Supplementary Figure 1d,e).
Embedding of the IONPs in the core of the chylomicrons was
corroborated by transmission electron cryomicroscopy (cryo-
TEM) as well as negative-stain transmission electron
microscopy (TEM) and high-angle annular dark-field scanning
transmission electron microscopy (HAADF-STEM) (Figure
1b and Supplementary Figure 2, respectively). The negative-
stain TEM and HAADF-STEM images appear to show
particles of slightly larger size than the cryo-TEM and
hydrodynamic diameter measurements, possibly due to
morphological changes caused by the sample preparation
(e.g., “flattening” of the particles during sample drying).
Importantly, the cryo-TEM analysis showed that IONPs
were inside the ACM and not on the surface, indicating stable
loading and low likelihood of nanoparticle shedding.
Incorporation in ACM did not alter the static and dynamic
properties of the IONPs: the quasi-static magnetization curves
of IONP-loaded ACM indicate that the individual particles are
Figure 2. MPS-based quantification of IONP-ACM uptake in tissues after cold exposure. (a) Schematic representation of the experimental
setup. F.T.: Fourier transform. (b, c) Specific and total uptake of IONP-ACM in different organs after 20 h of cold-exposure (n = 3 mice per
group). (d, e) Specific and total uptake of IONP-ACM in BAT and WAT depots after 20 h of cold-exposure (n = 4 mice per group). iBAT:
interscapular BAT, daPVAT: descending aorta PVAT, archPVAT: aortic arch PVAT. Data are presented as means ± SEM, * = p < 0.05, ** =
p < 0.01, *** = p < 0.001, two-tailed Student’s t test, 23 °C vs 4 °C.
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still sufficiently separated, showing no adverse influence of
chylomicron synthesis on the magnetization behavior of the
IONPs (Figure 1c). Nevertheless, both samples show a
nonsaturating magnetization curve at high fields. This linear
contribution has been often attributed to surface spin canting
in IONPs and is very likely due to a low amount of
crystallographic disorder as found in other IONP samples as
well.39−41 Similar results were obtained by dynamic magnet-
ization measurements using MPS, where no significant change
in the spectral magnetic signature was measured for individual
IONPs compared to IONP-loaded ACM (Figure 1d).
Recent studies have implicated activated BAT as a major site
for postprandial TG clearance.13,14,20,42 Therefore, we used
acute cold exposure as a means to induce chylomicron uptake
in vivo. Cold exposure strongly increases the requirement for
intracellular energy substrates to fuel thermogenesis and
therefore induces a rapid influx of glucose and lipids from
the circulation.4,6,8,13 A bolus of 5 mL/kg IONP-ACM was
injected in the tail vein of male C57BL/6-J mice following 20 h
of cold (4 °C) exposure (Figure 2a). MPS measurements of
tissue lysates revealed a dramatic increase in Fe uptake in the
BAT of cold-exposed animals in terms of Fe uptake both per
mg of tissue (0.2 ± 0.1 ng/mg (23 °C) vs 13.7 ± 3.2 ng/mg (4
°C), Figure 2b) and per whole tissue (13.6 ± 6.3 ng (23 °C) vs
864.6 ± 163.1 ng (4 °C), Figure 2c). Compared to visceral
WAT, subcutaneous WAT has a large population of inducible
brown adipocytes, also known as beige adipocytes, which
contribute to whole-body energy homeostasis.1,43,44 In line
with this, the subcutaneous inguinal WAT depot (iWAT) of
cold-exposed mice exhibited a tendency for increased Fe
uptake (0.09 ± 0.07 ng/mg (23 °C) vs 1.2 ± 0.4 ng/mg (4 °C)
for specific uptake, p = 0.0708, Figure 2b, and 23.8 ± 20.2 ng
(23 °C) vs 177.9 ± 53.4 ng (4 °C) for total uptake, p = 0.0541,
Figure 2c). In contrast, no increase in Fe uptake could be
observed in the visceral gonadal WAT depot (gWAT, Figure
2b,c). Cold exposure also induces shivering of skeletal muscle,
increasing its energy substrate requirements.45,46 Accordingly,
a significant increase in Fe uptake was also detected in the
quadriceps of cold-exposed mice (Figure 2b). These data
demonstrate that ACM uptake in metabolically active tissues is
quantifiable by MPS-based measurements.
To evaluate the detection limit of MPS-based measurement
of ACM uptake in adipose tissue, we performed a more
detailed analysis focusing on minor BAT depots as well as
depots of beige fat. Perirenal BAT (pBAT) is a small depot of
BAT adjacent to the kidneys. The perivascular adipose tissue
(PVAT) surrounding the thoracic aorta is another small fat
depot that has been reported to resemble BAT in several
studies.47,48 Fe uptake in pBAT and PVAT was increased in
cold-exposed animals to 10-fold and 12.2-fold, respectively
(Figure 2d). Thus, Fe uptake in the small BAT depots (pBAT
and PVAT) was detected by MPS and amounted to similar
increases as “classical” interscapular BAT upon cold exposure
(Figure 2d). To evaluate ACM uptake in beige adipocytes, we
compared visceral WAT, which typically has low numbers of
beige adipocytes, to subcutaneous WAT, which more readily
undergoes “beiging” upon cold exposure and has a high
number of beige adipocytes. Visceral WAT, i.e., gWAT,
mesenteric WAT (mWAT), and retroperitoneal WAT
(rWAT), did not show any increase in Fe uptake after short-
term cold exposure. On the other hand, the subcutaneous
adipose tissue depot triceps-associated WAT (triWAT)
showed a tendency for increased Fe uptake (p = 0.056, Figure
2e, Supplementary Figure 3), and the subcutaneous
interscapular WAT (isWAT) depot showed significantly
more Fe content after cold exposure (Figure 2e, Supple-
mentary Figure 3). Prolonged cold exposure is well described
to induce a strong beige phenotype in WAT.1−3 Therefore, to
induce a more robust beiging of the WAT, we also exposed
mice to 1 week of 4 °C and injected IONP-ACM. We analyzed
Fe uptake in all major WAT depots using MPS and found a
significant increase in all measured depots (Supplementary
Figure 4). This shows that MPS-based quantification of IONP-
ACM uptake can be used to measure beiging of WAT.
Interestingly, this also indicates that activated beige fat clears
chylomicrons from the circulation at least partly by whole-
particle uptake. Importantly, these findings demonstrate that
MPS-based quantification of lipid uptake has sufficient
sensitivity to detect increased lipid uptake in even the smallest
BAT depots, as well as in different depots of beige fat. The
limit of detection (LOD) for the third-harmonic amplitude A3
based MPS quantification was determined to be 2.1 ng of Fe
(Supplementary Figure 5). This enabled accurate quantifica-
tion of lipid uptake in BAT samples as small as 3 mg even in
mice housed at room temperature. Interestingly, the magnet-
ization curve of IONPs showed clearly linear correlation at
higher field values, meaning that the spin canting is
predominant for this commercial type of particles. Therefore,
only a reduced part of the nanoparticular iron will contribute
to the MPS signal. Thus, using particles with higher
crystallographic order may result in stronger signals and
lower detection limits.
To verify that the incorporated IONPs enter brown
adipocytes, the mature adipocytes from various adipose tissue
depots were separated from the stromal vascular fraction
(SVF) containing preadipocytes, endothelial cells, and other
nonadipocytes. In both BAT and iWAT, Fe uptake was
significantly increased in the mature adipocyte fraction
compared to the SVF fraction upon cold exposure (5.5 ±
1.0-fold and 1.8 ± 0.1-fold, respectively (Figure 3a,b), but not
in animals kept at ambient temperature. In gWAT, no
significant difference in Fe uptake between mature adipocytes
and SVF could be observed (Figure 3c). Additionally, TEM
and STEM images of BAT samples from cold-exposed, IONP-
ACM-injected mice showed both IONP-ACM apparently
undergoing endocytosis in the endothelium and deposition of
the IONPs specifically in brown adipocytes (Figure 3d and
Supplementary Figure 6). The latter was confirmed by energy-
dispersive X-ray spectroscopy (EDX) analysis of BAT tissue
sections (Supplementary Figure 7). IONP deposition in the
BAT of cold-exposed mice was also confirmed with Prussian
Blue staining, which showed bright blue signal in the BAT of
mice exposed to 4 °C, but not in those exposed to 23 °C
(Figure 3e). Therefore, we conclude that Fe content as
measured by MPS and MPI after IONP-ACM injection
represents true chylomicron uptake in BAT.
To examine the feasibility of using MPI together with the
MNP-loaded ACM for measuring lipid uptake and metabolic
activity in vivo, the suitability of ACM as MPI tracers was
assessed. The harmonic spectra of the IONP-ACM used in the
experiments above showed low amplitudes in the higher
harmonics compared to Resovist and were thus considered
inadequate for MPI. To improve the harmonic spectra of the
ACM and thus MPI signal, we focused on incorporating
nanoparticles with higher magnetic saturation. Zn-doping of
IONPs has previously been shown to increase saturation
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magnetization.49 Therefore, we focused on ZnMNPs and
incorporated these into ACM. The ZnMNPs used here had a
mean diameter of 10 ± 2 nm (as measured by TEM) and a
saturation magnetization of 110 emu/g. The resulting
ZnMNP-ACM showed high signal amplitudes and a rich
harmonic spectrum comparable to that of Resovist (Figure 4a).
As the signal amplitudes in the harmonic spectrum strongly
depend on the magnetization properties of the particles, we
also compared the magnetization curves of Resovist with that
of the ZnMNP-ACM. This showed that the ZnMNP-ACM
had a considerably higher saturation magnetization than
Resovist (Figure 4b). This indicates that, unlike IONP-ACM,
the magnetic properties of ZnMNP-ACM make them well
suited for MPI applications. The ZnMNP-ACM had a mean
diameter of 309.3 ± 13.2 nm (Supplementary Figure 8a), with
a similar size distribution to that of the IONP-ACM
(Supplementary Figure 8b). Incorporation of ZnMNPs in
the ACM was confirmed by HAADF-STEM and EDX
(Supplementary Figure 8c).
A systematic MPS evaluation of the ZnMNP-ACM as MPI
tracer was then performed with Resovist as reference.
Importantly, serial dilution of ZnMNP-ACM showed that
the MPS spectrum of ZnMNP-ACM scales linearly with
concentration (Figure 4c,d), which is necessary for quantitative
MPI. Additionally, encapsulation of the ZnMNPs in ACM
rendered their magnetic properties extremely insensitive to the
surrounding environment, unlike the current gold-standard
tracer for MPI, Resovist (Figure 4e). To compare the spatial
resolution performance of Resovist and ZnMNP-ACM, we also
measured the full width at half-maximum (fwhm) of point-like
phantoms, which showed slightly increased fwhm for ZnMNP-
ACM (Supplementary Figure 9). These data indicate that
ZnMNP-ACM are well suited for use as MPI tracers.
To demonstrate the performance of ZnMNP-ACM as MPI
tracers, ZnMNP-ACM were administered to mice, which were
then analyzed by whole-animal MPI scans (see Supplementary
Figure 10 for workflow). As shown in Figure 5, MPI enabled
clear visualization of lipid uptake in active BAT. For
comparison, control mice were injected with Resovist with
or without prior cold exposure. In contrast to ZnMNP-ACM-
injected mice, no MPI signal could be detected in the
interscapular area of Resovist-injected mice (Figure 5b). MPS-
based quantification of Resovist uptake in isolated organs
showed no uptake in BAT, iWAT, or gWAT (Supplementary
Figure 11). Quantification of ZnMNP content in the
interscapular area of mice injected with ZnMNP-ACM showed
a significant increase upon cold exposure (8.7 ± 1.0-fold,
Figure 5c,d).
After measuring tissue uptake of ZnMNP-ACM by whole-
body MPI scans, tissues were extracted from the mice and Fe
content was quantified again ex vivo using both MPI (Figure
6a−c) and MPS. MPI quantification of the Fe content in
extracted BAT showed a similar increase in Fe content as the
whole-body scans (10.4 ± 1.5-fold, Figure 6b). The imaging of
individual organs also confirmed that no signal was emanating
from organs proximal to the BAT, such as the lungs or heart
(Figure 6c). Although we saw a tendency for increased uptake
in iWAT in our MPS measurements, we were not able to
detect any differences with MPI (Figure 6c), possibly due to
slightly lower sensitivity when compared to ex vivo MPS. We
did not detect any differences in BAT uptake between mice
housed at 23 °C compared to mice housed in thermoneutral
conditions (30 °C, Supplementary Figure 12). This is in good
agreement with data on radioactively labeled artificial
chylomicrons, which are taken up by BAT through whole-
particle endocytosis mainly upon cold exposure.14 The results
from MPI- and MPS-based measurement of ZnMNP content
correlated strongly (r2 > 0.99), underlining that the selected
algorithm and the parameters for image reconstruction do not
adversely affect the quantitative information contained in the
raw data of the MPI measurement (Supplementary Figure 13).
As the injected ACM to a large extent end up in the liver, we
performed a long-term elimination study to investigate hepatic
clearance of the ZnMNP-ACM. This showed a significant
decrease of MNP content over time, with less than 20% of the
MPS signal remaining after 4 weeks (Supplementary Figure
14). To verify that the ZnMNP-ACM uptake measured by
MPI is indeed due to uptake of Zn-MNP-loaded ACM and not
free ZnMNPs, we also injected cold-exposed and control mice
with free ZnMNPs. We could not detect any uptake of
ZnMNPs in BAT using MPS in either group, suggesting that
our MPI results represent bona f ide ACM uptake (Supple-
mentary Figure 15). Although both zinc and iron are widely
considered to be biocompatible materials with minimal safety
concerns in the concentration range used in this study,50,51 we
also investigated the effect of both ZnMNP-ACM and Resovist
on brown adipocytes in vitro. We could not detect any
significant effect of the nanoparticles on brown fat differ-
entiation, cellular toxicity, or inflammatory cytokine expression
(Supplementary Figures 16 and 17). The in vivo toxicity of
zinc-doped iron oxide nanoparticles has been studied after
Figure 3. IONP-ACM are specifically taken up by the brown
adipocytes in BAT. (a−c) Fe uptake in SVF and MA in BAT,
iWAT, and gWAT after exposure to either 23 or 4 °C (n = 3 mice
per group). (d) TEM images showing uptake of IONP-ACM
(arrows) in the capillaries of BAT. (e) Representative images of
Prussian Blue/Pararosaniline-stained BAT from mice injected with
IONP-ACM after exposure to 23 or 4 °C. Data are presented as
means ± SEM. * = p < 0.05, two-tailed Student’s t test, SVF vsMA.
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intragastric administration, with no observed adverse effects.52
Additionally, intravenous administration of zinc oxide nano-
particles led to adverse effects in rats starting at 5 mg/kg.53
The zinc content in the MNPs used in this study is ∼6.5 times
lower than the iron content. This results in a zinc dose of
approximately 300 μg/kg for the ZnMNP-ACM-injected mice,
more than 15 times less than previously observed toxic doses
of zinc oxide nanoparticles. Therefore, we do not expect the
zinc doping to be a limiting factor in terms of toxicity of the
ZnMNP-ACM.
Finally, to validate the quantitative performance of our MPI
measurements, we compared our results with inductively
coupled plasma mass spectrometry (ICP-MS) measurements
of the same tissue samples. This showed a relatively small (1.46
± 0.15-fold) but significant increase in Fe concentration in
BAT from cold-exposed mice (Figure 7a) and a similar
increase (1.52 ± 0.23-fold, p = 0.0644) in Zn concentration
(Figure 7b). The concentrations of iron and zinc in cold-
exposed mice were still within the physiological ranges,
indicating low risk for toxicity. Liver and spleen Fe and Zn
concentrations were also both within physiological ranges
(Figure 7a,b).54,55 Comparison of our MPI-based (magnetic)
Fe uptake measurements on the ppm scale revealed that the
increased concentration of Fe in BAT after cold exposure is
not significantly different when measured by MPI or ICP-MS
(Figure 7c, Supplementary Figure 18). This shows that MPI-
based measurement of Fe uptake in BAT is comparable in
sensitivity to ICP-MS, albeit with much higher specificity due
to the fact that MPI measures only magnetic iron, and not
endogenous iron present in the tissues. Importantly, these data
show that quantification of ZnMNP-ACM-derived iron using
MPI is comparable in performance with the current gold
standard in iron quantification in tissue lysates.
The main limitation of the MPI-based quantification of lipid
uptake observed in this study was related to the small field of
view (FOV) of current preclinical MPI scanners. Using the
highest gradient strength to achieve a highly spatially resolved
image, the FOV is limited to around 2 × 2 × 1 cm3. A
multipatch acquisition scheme was used to increase the total
FOV, but due to signals generated from nanoparticles outside
the FOV, imaging artifacts at the edges of each individual
reconstruction were present. While we partly corrected for this
by “overscanning” the field-free point trajectory56 to remove
imaging artifacts from outside the FOV, we believe that these
Figure 4. MPS-based evaluation of ZnMNP-ACM as MPI tracer. (a) MPS amplitude spectrum of ZnMNP-ACM and Resovist. (b)
Magnetization curves of ZnMNP-ACM and Resovist. (c) MPS signal amplitude after serial dilution parametrized by A3. (d) MPS spectrum
shape after serial dilution parametrized by the harmonic ratio A5/A3. (e) Change of MPS signal shape (A5/A3) in different biological
environments. Data are presented as means ± SD of 20 repeated measurements. RPMI: Roswell Park Memorial Institute medium, FCS: fetal
calf serum.
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problems can be resolved better by a different system function
acquisition scheme using focus fields.57 While the resolution
achieved using ZnMNP-ACM was sufficient to accurately
resolve BAT using MPI, it is likely that improvements could be
made by further tracer optimization, as other studies have
demonstrated MPI tracers with an even larger relative increase
in fwhm compared to Resovist.58,59 Another potential
limitation in regard to absolute quantification of iron uptake
using MPI is the possibility of nanoparticle aggregation after
uptake, which may affect the MPI signal. Although the
ZnMNP-ACM do not show any altered magnetic behavior in
different biological environments, we cannot exclude that
intracellular processing of the ZnMNP-ACM results in some
degree of nanoparticle aggregation. However, since the MPI-
based quantification does not yield significantly different
results compared to ICP-MS, one would not expect this effect
to have a significant impact on the measurements. Given the
recent advancement of the development of human MPI
scanners,60 investigating lipid uptake and BAT metabolic
activity in human subjects without significant exposure to
radiation may be possible.
CONCLUSIONS
Current strategies for the quantification of in vivo lipid uptake
rely on radioactive labeling of fatty acids, cholesterol, or other
components of the lipoprotein particles.13,14,42,45,61−63 While
this method has benefits in terms of versatility and by being a
bona f ide measure of lipid uptake, there are clear practical and
Figure 5. MPI-based quantification of ZnMNP-ACM uptake in BAT after cold exposure. (a) Representative whole-body MRI and MPI
images of mice injected with ZnMNP-ACM after exposure to either 23 or 4 °C. (b) Representative whole-body MRI and MPI images of mice
injected with Resovist after exposure to either 23 or 4 °C. (c) Representative MPI images of the interscapular area (red box) with MRI
overlay. (d) ZnMNP-ACM uptake in BAT after 20 h of cold-exposure measured from whole-animal MPI scans (n = 4 mice per group). Data
are presented as means ± SEM relative to uptake at 23 °C in each tissue, ** = p < 0.01, *** = p < 0.001, two-tailed Student’s t test, 23 °C vs
4 °C.
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safety-related drawbacks. Apart from the health concerns
inherent in working with radioactive substances, the most
common radioisotope for metabolic imaging is 18F, which has a
half-life of 110 min, meaning on-site cyclotrons are often
required. In this work, we have demonstrated a safe, fast, and
highly sensitive technique for measuring chylomicron uptake in
metabolically active tissues using IONP-loaded chylomicrons
and MPS. Furthermore, we have shown that chylomicrons
loaded with strongly magnetic ZnMNPs are highly suitable for
MPI imaging, enabling quantification of MNP uptake with
similar sensitivity to gold-standard ex vivo methods such as
ICP-MS. Taken together, using these tracers, we were able to
noninvasively image and quantify chylomicron uptake in
metabolically active tissues with great accuracy without relying
on radioactive isotope labeling.
METHODS
Synthesis of Artificial MNP-Loaded Chylomicrons. Artificial
chylomicrons were synthesized by mixing cholesterol (Sigma-Aldrich,
St. Louis, MO, USA), phosphatidylcholine (Avanti Polar Lipids,
Alabaster, AL, USA), and triglycerides (soy bean oil, Sigma-Aldrich)
in a 1:1:16 ratio, unless otherwise described. The mixture was
dissolved in chloroform (Sigma-Aldrich), and 500 μg of super-
paramagnetic IONPs (Sigma-Aldrich, product no. 900088) or
ZnMNPs (see below) were added. The mixture was then placed in
a rotary evaporator with a heated water bath (60 °C) at 75 mbar until
all chloroform had evaporated. The resulting lipid film was mixed with
1 mL of phosphate-buffered saline and sonicated with a probe
sonicator at maximum power for 10 min with intermittent cooling on
ice. Before use, the MNP-ACM suspension was filtered through a 1
μm poly(ether sulfone) (PES) syringe filter (GE Healthcare Life
Sciences, Chicago, IL, USA) and immediately characterized using
DLS (ZetaSizer 90S, Malvern Panalytical, Malvern, UK).
Zn-Doped Iron Oxide Nanoparticles. The synthesis of zinc
ferrite nanocrystals was prepared by incorporating a zinc precursor in
a triethylene glycol and iron acetylacetonate mixture as described
previously in a high-temperature and high-pressure reaction.64
Figure 6. MPI-based quantification of ZnMNP-ACM uptake in isolated organs after cold exposure. (a) Representative MPI images of excised
BAT, with representative photograph of BAT at the same scale. (b) ZnMNP-ACM uptake in excised tissues after 20 h cold-exposure
measured from single-organ MPI scans (n = 4 mice per group). Data are shown as fold-change over Fe content in each organ of the mice
housed at 23 °C. (c) Representative MPI images of isolated organs from cold-exposed mice injected with ZnMNP-ACM. Representative
photographs of the organs imaged are shown below each MPI image. Data are presented as means ± SEM relative to uptake at 23 °C in each
tissue, ** = p < 0.01, *** = p < 0.001, two-tailed Student’s t test, 23 °C vs 4 °C.
Figure 7. ICP-MS-based quantification of ZnMNP-ACM uptake in
BAT after cold exposure. (a) ICP-MS measurements of Fe
concentration in tissue samples from ZnMNP-ACM-injected
mice (n = 4 mice per group). (b) ICP-MS measurements of Zn
concentration in tissue samples from ZnMNP-ACM-injected mice.
(c) Comparison between increase in Fe content in BAT upon cold
exposure and ZnMNP-ACM injection, as measured by ICP-MS and
MPI (n = 4 mice per group). Ctrl: control mice, not injected with
ZnMNP-ACM. Data are presented as means ± SEM, * = p < 0.05,
two-tailed Student’s t test, 23 °C vs 4 °C or ICP-MS vs MPI.
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ZnMNP Surface Functionalization. To render the nanoparticles
hydrophobic, oleic acid was used to coat the surface. Briefly, oleic acid
(0.5 mL) was dissolved in hexane (5 mL) under magnetic stirring.
Then crude nanoparticle suspension (0.5 mL) was added, and the
reaction was allowed to proceed overnight at room temperature. The
black hexane layer was isolated and washed three times with water to
remove triethylene glycol and once with ethanol to remove excess
oleic acid. The oleic acid-coated nanoparticles were collected by
magnetic decantation and redispersed in hexane. The surface coating
was assessed by infrared spectroscopy using an ATR-FTIR instrument
(Spectrum 100, PerkinElmer) as shown in Supplementary Figure 19.
ZnMNP Material Characterization. The size and morphology of
the crystallites was assessed by TEM by measuring at least 300
particles using the image processing software ImageJ. The spherical
ZnMNPs have an average size of 10 ± 2 nm. The magnetic properties
were measured on a superconducting quantum interference vibrating
sample vibrometer (SQUID-VSM, MPMS 3, Quantum Design, USA).
Analysis of MNP-ACM Uptake in Vivo. Wild-type male 8−10-
week-old C57Bl/6-J mice were purchased from Janvier and randomly
divided into two groups (cold exposure or control). The mice were
housed at either 23 or 4 °C for 20 h or 1 week prior to injection, with
free access to chow and water. A bolus of 5 mL/kg of MNP-ACM
suspension was injected in the tail vein, immediately followed by an
additional 4 h at either 30, 23, or 4 °C, after which the animals were
sacrificed. The investigators could not be blinded to the treatment
groups due to the obvious differences in temperatures. All animal
experiments were approved by the Landesamt für Natur, Umwelt and
Verbraucherschutz, Nordrhein-Westfalen, Germany. The governmen-
tal approval number is 84-02.04.2016.A171. A total number of 65
mice were used in this study.
MPS Measurements of Tissue Lysates. Tissues were extracted with
ceramic-coated surgical tools and digested overnight with Proteinase
K (Roche, Basel, Switzerland). Digested tissues were homogenized by
adding 5−10 glass beads (Sigma-Aldrich) followed by rapid shaking
for 20 s in CapMix (3M ESPE, Seefeld, Germany). A 100 μL portion
of the homogenized lysate was transferred to a PCR tube (Applied
Biosystems, Foster City, CA, USA, MicroAmp fast reaction tube with
cap) and measured in the MPS system as described above. For
measurements of MNP uptake in different tissue compartments, BAT,
iWAT, and gWAT were digested with collagenase, and mature
adipocytes were separated from other cells by centrifugation. Prior to
quantification a serial dilution of a reference sample was measured by
MPS to determine the MNP-specific detection sensitivity from the
slope of the calibration curve, i.e., the normalized third-harmonic
amplitude, A3* = A3/m(Fe). The iron content of the individual tissue
sample was determined from the measured A3 normalized to A3* of
the reference. For larger sample sizes a correction of the signal
amplitude was necessary taking the spatial dependence of the coil
sensitivity into account.65 To further reduce the quantification
uncertainty, a subsequent correction of the MNP-specific amplitude
A3* was performed as previously described for the quantification of
MNPs in biological environments and cells.66,67
MPI Measurements. A preclinical MPI scanner (25/20 FF, Bruker
BioSpin, Billerica, MA, USA) was used for all MPI measurements. All
MPI measurements were performed post mortem. A 3D signal
excitation was performed in the x/y/z-direction, with slightly different
frequencies of ∼24.51/26.04/25.25 kHz and excitation amplitudes of
12 mT. Spatial encoding was achieved by static magnetic gradient
fields with gradient strengths of 1.25/1.25/2.5 T/m. Magnetic
response signals, generated by the magnetic nanoparticles, were
acquired with a gradiometric receive-only coil.68 The acquired signals
were used for image reconstruction of the particle distribution based
on the system function approach,69,70 after background correction by
subtraction of empty scanner measurements and truncation based on
the signal-to-noise ratio.
A system function was acquired by measurements of a small
reference sample of MNPs at multiple positions all over the FOV.
Due to the small FOV size of MPI, each mouse was measured at four
different positions for 10 s (500 averages), and particle distributions
were reconstructed individually. The resulting images were joined in
one final image covering a FOV of 80 × 25 × 19 mm3 with a voxel
size of 1 mm3. To remove noise from the final images, a threshold
intensity was determined by reconstructions of empty scanner
measurements. Detailed lists of all MPI-related reconstruction
parameters for mice and organs are given in Supplementary Table 1
and 2, respectively. For Fe quantification using MPI data, magnetic
iron mass was correlated to voxel intensities based on the system
function acquired with a reference sample with known mass. For
color-coding of MPI images, the intensity signal was rescaled from
arbitrary units of voxel intensity to relative Fe distribution in percent
by setting the sum of all voxel intensities in the images to one.
MRI Measurements. Anatomical reference scans were acquired
using a preclinical 1 T ICON MRI system (Bruker BioSpin) equipped
with a whole-body receive coil. The same animal bed was used for the
MRI and MPI scans without moving the mice between each
acquisition. Coronal slices of each mouse were acquired using a
FLASH sequence. A detailed list of all MRI-related imaging
parameters is given in Supplementary Table 3. Image overlays of
MRI and MPI images were performed with the help of fiducial
markers. Co-registration of the MPI and MRI images was performed
the following way: First, MPI measurements of fiducial markers
containing MNPs were performed to get reference information on
which location of the MPI-FOV corresponds to which location on the
animal bed. Before the MRI measurements of each mouse, a photo
was taken. An additional fiducial marker, containing only water, was
positioned below the animal bed to be able to overlay the MRI image
with the photo. Combined with the information obtained from the
MPI measurements of the fiducial markers, the MPI and MRI images
can be overlaid. For MPI-based uptake quantification in whole-body
scans, the ROI (region of interest) for each mouse was selected by
identifying the location of the interscapular BAT in the MRI scans,
based on the surrounding anatomy.
Quasi-static Magnetic Characterization. The quasi-static
magnetization M of the samples as a function of applied field strength
H (up to 4000 kA/m) was measured at room temperature using a
superconducting quantum interference device (SQUID)-based
susceptometer (QD-MPMS-XL-5, Quantum Design, USA). A
detailed description of the magnetization measurement procedure is
found elsewhere.71 Here, we used a polycarbonate capsule as a sample
container and a clear straw as a sample holder. The background signal
caused by the empty capsule and diamagnetic susceptibility of the
dispersion medium was subtracted from the measured signal. The
presented magnetization curve results from normalizing the magnetic
moment of the sample to its iron content and is given in Am2 per
kilogram iron. Therefore, the iron content of the respective sample
was determined using a phenanthroline-based iron assay described
elsewhere.72 Measurement data were fitted by the weighted sum of
Langevin functions assuming a log-normal distribution of non-
interacting magnetic moments.73
Dynamic Magnetic Characterization. The dynamic magnetic
characterization of MNP was performed by magnetic particle
spectroscopy using a commercial MPS device (MPS-3, Bruker
Biospin, GER).65 Based on the same physical principle as magnetic
particle imaging, waiving any spatial encoding, MPS allows for pre-
evaluation of the MPI performance of MNP. For the measurement a
PCR tube (Applied Biosystems, MicroAmp fast reaction tube with
cap) containing a sample volume of up to 100 μL was placed in the
MPS system. By exposing the sample to a sinusoidal magnetic field
(amplitude Bp up to 25 mT, f 0 of 25 kHz) the induced magnetization
is measured by gradiometric pick-up coils. Fourier transformation of
the measured time signal results in spectral components showing
distinct amplitudes at odd multiples of the drive frequency f 0 evoked
by the characteristic nonlinear magnetization behavior of MNP. In
this study all measurements were performed at 37 °C. The LOD of
the third-harmonic amplitude A3 was determined according to
guidance of the International Union of Pure and Applied Chemistry
(IUPAC) as 3× the standard error of the regression y-intercepts
(residual standard deviation) in the calibration curve divided by the
calibration curve slope.
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Electron Microscopy. The microscopy work has been conducted
in the “Laboratorio de Microscopias Avanzadas” at “Instituto de
Nanociencia de Aragoń−Universidad de Zaragoza”.
Cryo-TEM. To prepare the sample, a drop of the IONP-ACM
suspension was deposited on the carbon side of the copper grid
(Electron Microscopy Sciences, Spain) and vitrified by immersion in
liquid ethane using an automated device (FEI Vitrobot, The
Netherlands). All subsequent manipulations of the grid were carried
out in liquid nitrogen, and the TEM images were acquired under
cryogenic conditions using a cryo-transfer holder (Gatan Inc., USA).
Images were acquired using a Tecnai T20 microscope (FEI Company,
The Netherlands) operating at 200 kV.
Negative-Stain TEM. For TEM analysis, a carbon-coated 300 mesh
copper grid was placed on top of a 5 μL droplet of sample (sample
facing downward) for 4 min. The grid was then rinsed with a drop of
distilled water and subsequently transferred to a 3 μL drop of NANO-
W (2% in water; Nanoprobes) for 2 min for negative staining. The
grid was quickly rinsed with a drop of water for 1 min to remove the
excess staining solution and dried, contacting the grid edge with filter
paper. The grid was stored in an EM grid box under vacuum for future
observation by TEM.
EDX Analysis. For electron microscopy analysis, the excised BAT
tissue samples were cut into 1 mm3 pieces and fixed with 2.5%
glutaraldehyde/2% paraformaldehyde in 0.1 M pH 7.4 sodium
phosphate buffer for 24 h at room temperature and subsequently for 5
days at 4 °C. Then, the samples were washed for 30 min four times
with sodium phosphate buffer, postfixed with 2% osmium, rinsed,
dehydrated, and embedded in Durcupan resin (Fluka, Sigma-Aldrich).
Semithin sections (1.5 μm) were cut with an Ultracut UC-6
ultramicrotome (Leica, Heidelberg, Germany) and stained lightly
with 1% toluidine blue. Finally, ultrathin sections (0.08 μm) were cut
with a diamond knife, stained with lead citrate (Reynolds solution),
and examined under a 300 kV FEI Tecnai F30 transmission electron
microscope (FEI Company) equipped with an HAADF detector
enabling working in STEM mode for performing EDX analysis.
Brown Adipocyte Culture and Differentiation. Brown
preadipocytes were isolated, differentiated, and stained with RedO-
oil as previously described.74
Prussian Blue Staining. Tissue samples were fixed in 4% PFA for
16 h, dehydrated, and embedded in paraffin. Sections of 5 μm were
cut and stained with iron stain kit HT20-1KT (Sigma-Aldrich)
according to the manufacturer’s instructions.
ATP Assay. ATP analysis was performed with ATPlite
Luminescence Assay System (PerkinElmer, Waltham, MA, USA)
according to the manufacturer’s instructions.
RT-qPCR. mRNA was isolated from brown adipocytes using Trizol
(ThermoFisher Scientific, Waltham, MA, USA). Reverse transcription
was performed with a ProtoScript II First Strand cDNA synthesis kit
(New England Biolabs, Ipswitch, MA, USA). qPCR was performed
with Power SYBR Green PCR Master Mix (ThermoFisher Scientific).
Data Availability. The raw data that support the findings of this
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